Denis Delval
Algemeen Directeur bij LFB Biomedicaments SA
Profiel
Denis Delval is currently the President & Chief Executive Officer at Ethypharm SAS since 2022 and also holds the position of Chairman & Chief Executive Officer at LFB Biomedicaments SA since 2017.
Previously, he was the Chairman & Chief Executive Officer at LFB Biotechnologies SASU and the Chief Executive Officer at Laboratoire Français du Fractionnement et des Biotechnologies.
Dr. Delval holds a doctorate degree from INSEAD and an undergraduate degree from ESSEC Business School.
Actieve functies van Denis Delval
Bedrijven | Functie | Begin |
---|---|---|
LFB Biomedicaments SA
LFB Biomedicaments SA Pharmaceuticals: MajorHealth Technology LFB Biomedicaments SA is a French pharmaceutical company that manufactures pharmaceutical preparation products. The company is a subsidiary of the Government of France and is based in Les Ulis, France. The company was founded in 2006 and Denis Delval has been the CEO of the company since 2017. | Algemeen Directeur | 23-12-2017 |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | Algemeen Directeur | 10-10-2022 |
Eerdere bekende functies van Denis Delval
Bedrijven | Functie | Einde |
---|---|---|
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Algemeen Directeur | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Algemeen Directeur | - |
Opleiding van Denis Delval
ESSEC Business School | Undergraduate Degree |
INSEAD | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
LFB Biomedicaments SA
LFB Biomedicaments SA Pharmaceuticals: MajorHealth Technology LFB Biomedicaments SA is a French pharmaceutical company that manufactures pharmaceutical preparation products. The company is a subsidiary of the Government of France and is based in Les Ulis, France. The company was founded in 2006 and Denis Delval has been the CEO of the company since 2017. | Health Technology |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | Health Technology |